Thermo Fisher ups clinical, commercial capabilities with $50m investment
Thermo Fisher Scientific is investing $50m to further expand its biologic drug substance capabilities for both clinical and commercial supply.
Archives for April 25, 2019
Sygnature taps SilcsBio for drug design software
Sygnature Discovery is using SilcsBio’s software suite for structure-based drug design – classifying thousands of ideas in “just a few hours.”
TX-based Moleculin turns to Poland for accelerated patient recruitment
Centralized databases, reduced competition for patients, and higher starting doses are among some of the benefits to conducting research in Poland, which ranks seventh in Europe for clinical trial participation, says Moleculin CEO.
hyperCore sets its sights on global expansion, improved efficiencies: CEO
Eight site networks team up to form hyperCore International – “the network of networks” – with locations from Lima, Peru to Calgary, Canada, says CEO, who stresses the company's partnership model as key to its success.
GSK ramps up Shingrix production with $100m investment
GSK announces that it will spend $100m to expand production capacity for components of Shingrix, amid a US market where demand outstrips supply of its shingles vaccine.
Teva gets first approval for generic opioid reversal nasal spray
The US FDA approves the first generic naloxone nasal spray for opioid overdose, after prioritising the review of generic opioid reversal products.